Switch theme
Sign up to access all valuation multiples
Medicalgorithmics SA is a medical technology company. It is engaged in the development of Digital Signal Processing (DSP) algorithms development and software and hardware electronics design for medical applications.
2005
476
LTM Revenue $7.6M
LTM EBITDA -$2.8M
$66.3M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Medicalgorithmics has a last 12-month revenue (LTM) of $7.6M and a last 12-month EBITDA of -$2.8M.
In the most recent fiscal year, Medicalgorithmics achieved revenue of $11.4M and an EBITDA of $0.6M.
Medicalgorithmics expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Medicalgorithmics valuation multiples based on analyst estimates| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue | $7.6M | XXX | $11.4M | XXX | XXX | XXX |
| Gross Profit | -$4.0M | XXX | $9.5M | XXX | XXX | XXX |
| Gross Margin | -53% | XXX | 83% | XXX | XXX | XXX |
| EBITDA | -$2.8M | XXX | $0.6M | XXX | XXX | XXX |
| EBITDA Margin | -37% | XXX | 5% | XXX | XXX | XXX |
| EBIT | -$3.8M | XXX | $0.1M | XXX | XXX | XXX |
| EBIT Margin | -50% | XXX | 1% | XXX | XXX | XXX |
| Net Profit | -$3.7M | XXX | -$0.2M | XXX | XXX | XXX |
| Net Margin | -49% | XXX | -1% | XXX | XXX | XXX |
| Net Debt | XXX | XXX | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of May 30, 2025, Medicalgorithmics's stock price is PLN 26 (or $7).
Medicalgorithmics has current market cap of PLN 261M (or $69.1M), and EV of PLN 250M (or $66.3M).
See Medicalgorithmics trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $66.3M | $69.1M | XXX | XXX | XXX | XXX | $-0.38 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of May 30, 2025, Medicalgorithmics has market cap of $69.1M and EV of $66.3M.
Medicalgorithmics's trades at 5.8x EV/Revenue multiple, and 112.0x EV/EBITDA.
Equity research analysts estimate Medicalgorithmics's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Medicalgorithmics has a P/E ratio of -18.5x.
See valuation multiples for Medicalgorithmics and 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $69.1M | XXX | $69.1M | XXX | XXX | XXX |
| EV (current) | $66.3M | XXX | $66.3M | XXX | XXX | XXX |
| EV/Revenue | 8.8x | XXX | 5.8x | XXX | XXX | XXX |
| EV/EBITDA | -23.7x | XXX | 112.0x | XXX | XXX | XXX |
| EV/EBIT | -17.5x | XXX | 453.2x | XXX | XXX | XXX |
| EV/Gross Profit | -16.4x | XXX | n/a | XXX | XXX | XXX |
| P/E | -18.5x | XXX | -451.1x | XXX | XXX | XXX |
| EV/FCF | n/a | XXX | -22.5x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialMedicalgorithmics's last 12 month revenue growth is 57%
Medicalgorithmics's revenue per employee in the last FY averaged $24K, while opex per employee averaged $20K for the same period.
Medicalgorithmics's rule of 40 is 93% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Medicalgorithmics's rule of X is 105% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Medicalgorithmics and other 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 57% | XXX | 17% | XXX | XXX | XXX |
| EBITDA Margin | -37% | XXX | 5% | XXX | XXX | XXX |
| EBITDA Growth | -108% | XXX | n/a | XXX | XXX | XXX |
| Rule of 40 | 93% | XXX | 62% | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | 105% | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | $24K | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | $20K | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | 0% | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 82% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Philips | XXX | XXX | XXX | XXX | XXX | XXX |
| Perspective Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
| SmartVest | XXX | XXX | XXX | XXX | XXX | XXX |
| InfuSystem | XXX | XXX | XXX | XXX | XXX | XXX |
| Myomo | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Medicalgorithmics acquired XXX companies to date.
Last acquisition by Medicalgorithmics was XXXXXXXX, XXXXX XXXXX XXXXXX . Medicalgorithmics acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| When was Medicalgorithmics founded? | Medicalgorithmics was founded in 2005. |
| Where is Medicalgorithmics headquartered? | Medicalgorithmics is headquartered in Poland. |
| How many employees does Medicalgorithmics have? | As of today, Medicalgorithmics has 476 employees. |
| Is Medicalgorithmics publicy listed? | Yes, Medicalgorithmics is a public company listed on WAR. |
| What is the stock symbol of Medicalgorithmics? | Medicalgorithmics trades under MDG ticker. |
| When did Medicalgorithmics go public? | Medicalgorithmics went public in 2011. |
| Who are competitors of Medicalgorithmics? | Similar companies to Medicalgorithmics include e.g. Philips, Perspective Therapeutics, SmartVest, InfuSystem. |
| What is the current market cap of Medicalgorithmics? | Medicalgorithmics's current market cap is $69.1M |
| What is the current revenue of Medicalgorithmics? | Medicalgorithmics's last 12 months revenue is $7.6M. |
| What is the current revenue growth of Medicalgorithmics? | Medicalgorithmics revenue growth (NTM/LTM) is 57%. |
| What is the current EV/Revenue multiple of Medicalgorithmics? | Current revenue multiple of Medicalgorithmics is 8.8x. |
| Is Medicalgorithmics profitable? | Yes, Medicalgorithmics is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Medicalgorithmics? | Medicalgorithmics's last 12 months EBITDA is -$2.8M. |
| What is Medicalgorithmics's EBITDA margin? | Medicalgorithmics's last 12 months EBITDA margin is -37%. |
| What is the current EV/EBITDA multiple of Medicalgorithmics? | Current EBITDA multiple of Medicalgorithmics is -23.7x. |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
